Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,407 | 7,106 | 5,816 | 8,654 | 9,077 |
| Receivables | 20,486 | 19,453 | 16,010 | 10,495 | 6,201 |
| Inventories | 13,831 | 12,931 | 14,325 | 15,224 | 11,168 |
| TOTAL | $43,161 | $40,014 | $37,157 | $34,729 | $27,445 |
| Non-Current Assets | |||||
| PPE Net | 10,571 | 10,175 | 10,095 | 9,770 | 10,098 |
| Intangibles | 7,241 | 6,341 | 6,341 | 6,341 | 6,341 |
| Other Non-Current Assets | 26,873 | 27,123 | 21,104 | 19,879 | 2,616 |
| TOTAL | $44,686 | $43,639 | $37,540 | $35,990 | $19,055 |
| Total Assets | $87,846 | $83,654 | $74,696 | $70,719 | $46,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,430 | 4,296 | 4,306 | 295 | 251 |
| Accounts payable and accrued liabilities | 2,607 | 2,714 | 2,891 | 3,609 | 1,875 |
| Accrued Expenses | 6,228 | 5,302 | 11,885 | 11,158 | 5,929 |
| TOTAL | $14,015 | $13,050 | $19,159 | $19,078 | $12,078 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,245 | 3,280 | 3,317 | 3,355 | 3,578 |
| Deferred Revenues | 13 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 10,932 | 8,255 | 5,597 | 3,179 | 711 |
| TOTAL | $15,581 | $13,021 | $9,124 | $6,547 | $4,305 |
| Total Liabilities | $29,595 | $26,071 | $28,283 | $25,625 | $16,382 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,068,273 | 1,068,273 | 1,017,781 | 1,013,915 | 1,013,915 |
| Common Shares | 1,068 | 1,068 | 1,018 | 1,014 | 1,014 |
| Retained earnings | -115,774 | -116,389 | -119,715 | -120,422 | -135,356 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $58,251 | $57,583 | $46,414 | $45,095 | $30,117 |
| Total Liabilities And Equity | $87,846 | $83,654 | $74,696 | $70,719 | $46,500 |